yohimbine has been researched along with carvedilol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Komori, K; Nagao, T; Seki, N; Suzuki, H | 1 |
| Ebe, R; Fukase, S; Horikoshi, Y; Inagawa, K; Osakabe, N; Saito, A; Shibata, M | 1 |
3 other study(ies) available for yohimbine and carvedilol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Alpha and beta adrenoceptor blocking action of carvedilol in the canine mesenteric artery and vein.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Dogs; Electrophysiology; Evoked Potentials; Female; Guinea Pigs; Isoproterenol; Male; Mesenteric Arteries; Mesenteric Veins; Norepinephrine; Propanolamines; Synaptic Transmission; Yohimbine | 1988 |
Onset of a hypotensive effect following ingestion of flavan 3-ols involved in the activation of adrenergic receptors.
Topics: Adrenergic Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Butoxamine; Cacao; Carbazoles; Carvedilol; Catechin; Epinephrine; Flavonoids; Gene Expression Regulation; Heart Rate; Male; Nitric Oxide Synthase Type III; Phosphorylation; Prazosin; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic; Yohimbine | 2016 |